Has Chrystal Webb, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,420 in general payments to Chrystal Webb, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chrystal Webb, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chrystal Webb, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chrystal Webb, MD

Vascular & Interventional Radiology · Columbus, OHNPI 1366855165

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,787 of the $8,420 with a category attached, or 68.7%. Penumbra, Inc. accounts for 96.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $5,345 and has fallen 50.5% since, to $2,648 in 2025.

$8,420in general payments, 2019–2025

Across 35 payments — averaging $240.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Penumbra, Inc.$8K
Terumo Medical Corporation$144
Cardiovascular Systems Inc.$103
Merck$19
Bard Peripheral Vascular, Inc.$17
Seagen Inc.$17
plus $17 from 1 others

What the payments were for

Travel & lodging$5,78769%
Food & beverage$2,63331%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Penumbra, Inc.	24	$8,103
Terumo Medical Corporation	1	$144
Cardiovascular Systems Inc.	6	$103
Merck	1	$19
Bard Peripheral Vascular, Inc.	1	$17
Seagen Inc.	1	$17
Medtronic	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,420 in reported general payments places this provider in the 80th percentile of 125 vascular & interventional radiology providers in Ohio.

See all vascular & interventional radiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$65,261

Medicare patients

282

Services billed

838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Columbus

James McGrawColumbus$222K
Fred MoesleinColumbus$205K
Mamdouh KhayatColumbus$159K
Lucy la PernaColumbus$105K
Michael ClineColumbus$35K
Ali RikabiColumbus$31K
Amit GuptaColumbus$8K
Omar MohamedColumbus$5K
Laurian DeanColumbus$4K
David KirtlandColumbus$4K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →